One of the S&P 500’s top stocks of 2026 just entered correction territory. The fundamental case hasn’t...
Revenue up 40% and a $7.7B backlog. The real debate is the valuation.
An 86% EPS beat today just made insurance the most interesting trade in the market.
A $10B Crinetics deal, a fifth commercial pillar, and Q2 earnings that will define the acquisition thesis.
A Meta nuclear PPA and record Q1 adjusted EBITDA are not yet in the price.
Record profit, a $265B US bet, and a market asking the wrong question.
Every AI agent needs an identity. Okta wants to be the gatekeeper.
Operating earnings jumped about 54% and guidance moved sharply higher. The sector read-through is the bigger story.
A record-breaking Q2 beat just sent shares surging 7%. Here's why the real story runs deeper.
